3,011
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Piezo1 activation facilitates ovarian cancer metastasis via Hippo/YAP signaling axis

, , , , , , , , & show all
Pages 159-166 | Received 08 Feb 2022, Accepted 05 Jul 2022, Published online: 08 Aug 2022

References

  • Xu H, Chen Z, Li C. The prognostic value of Piezo1 in breast cancer patients with various clinicopathological features. Anti-Cancer Drugs. 2021;32(4):448–455.
  • Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151–156.
  • McKenzie AJ, Hicks SR, Svec KV, et al. The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation. Sci Rep. 2018;8(1):1–20.
  • Rahimi Gorji M, Debbaut C, and Steuperaert M, et al. CFD model of the interstitial fluid pressure (IFP) in realistic tumor geometries of peritoneal metastases from ovarian cancer. 17th National Day on Biomedical Engineering, Singapore, 2018.
  • Li J, Hou B, Tumova S, et al. Piezo1 integration of vascular architecture with physiological force. Nature. 2014;515(7526):279–282.
  • Yang X-N, Y-P L, Liu -J-J, et al. Piezo1 is as a novel trefoil factor family 1 binding protein that promotes gastric cancer cell mobility in vitro. Dig Dis Sci. 2014;59(7):1428–1435.
  • Yu JL, Liao HY. Piezo-type mechanosensitive ion channel component 1 (Piezo1) in human cancer. Biomed Pharmacother. 2021;140:111692.
  • Dalghi MG, Clayton DR, Ruiz WG, et al. Expression and distribution of PIEZO1 in the mouse urinary tract. Am J Physiol Renal Physiol. 2019;317(2):F303–F21.
  • Zhou W, Liu X, van Wijnbergen JWM, et al. Identification of PIEZO1 as a potential prognostic marker in gliomas. Sci Rep. 2020;10(1):1–14.
  • Etem EÖ, Ceylan GG, Özaydın S, et al. The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma. Adv Clin Exp Med. 2018;27(8):1025–1031.
  • Jiang L, Y-d Z, W-x C. The function of the novel mechanical activated ion channel Piezo1 in the human osteosarcoma cells. Med Sci Monit. 2017;23:5070.
  • Huang Z, Sun Z, Zhang X, et al. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration. Biosci Rep. 2019;39(3):BSR20181679.
  • He C, Mao D, Hua G, et al. The Hippo/ YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression. EMBO Mol Med. 2015;7(11):1426–1449.
  • Hall CA, Wang R, Miao J, et al. Hippo pathway effector Yap is an ovarian cancer oncogene. Cancer Res. 2010;70(21):8517–8525.
  • Novak CM, Horst EN, Lin E, et al. Compressive stimulation enhances ovarian cancer proliferation, invasion, chemoresistance, and mechanotransduction via CDC42 in a 3D bioreactor. Cancers (Basel). 2020;12(6):1521.
  • Van Soldt BJ, Cardoso WV. Hippo‐Yap/Taz signaling: complex network interactions and impact in epithelial cell behavior. Wiley Interdiscip Rev. 2020;9(3):e371.
  • Wei Y, Li W. Calcium, an emerging intracellular messenger for the hippo pathway regulation. Front Cell Dev Biol. 2021;9:1738.
  • Liu Z, Wei Y, Zhang L, et al. Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ. Oncogene. 2019;38(1):120–139.